Tamfinder market filing
Global
Aug 29, 2026
Menstruation app that is not only focused on women, but also on nonbinary/trans people, as well as alternate ways of logging/sharing data.
TAM // TOTAL ADDRESSABLE MARKET
Low confidence$950M to $2.5B
SAM // SERVICEABLE ADDRESSABLE MARKET
Low confidence$57M to $140M
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
Real differentiation, real ceiling
The inclusive identity angle is a genuine wedge: no top-3 incumbent (Flo, Clue, Natural Cycles) has meaningfully addressed nonbinary or trans users, and the 250M-download incumbent base is largely built on a cis-female frame. The problem is that the addressable user segment willing to pay for this differentiation is a fraction of the 1.8 billion reproductive-age population, and your $40/year price point caps SAM hard. Your weakest link is the SOM path: Flo's $56M settlement and 420M downloads mean you are not just competing on features but on institutional trust that takes years to build, and privacy-forward positioning alone did not save Clue from stalling at 10M monthly active users against Flo's 70M.
Key risk
Clue proved privacy positioning alone cannot close a 7x monthly-user gap against Flo's network scale.
TAM // TOTAL ADDRESSABLE MARKET
Low confidence$950M to $2.5B
stated: $950M
Global menstrual health app market baseline; multiple reports span $954M to $2.49B in 2024-2026, reflecting wide methodological variance.
Top-down analyst reports diverge by 2.6x on baseline year estimates; bottom-up user-count method yields $1.4B, sitting mid-range but closer to conservative end.
SAM // SERVICEABLE ADDRESSABLE MARKET
Low confidence$57M to $140M
stated: $57M
Reachable slice targets inclusive-identity users and privacy-conscious segments globally, applying smartphone access, willingness-to-pay, and differentiation filters.
Top-down filter yields $57M; bottom-up user-count build yields $140M. Methods diverge by 2.5x, exceeding the 2x threshold, so conservative bound is displayed.
SOM 3YR // SERVICEABLE OBTAINABLE MARKET
$4.3M
Year-3 capture of ~3.5% of conservative SAM, assuming a competent launch with strong community distribution but constrained by incumbent scale and trust deficit.
>Methodology
TAM TOP-DOWN
Four analyst reports place the global menstrual health app market between $954M (InsightAce, 2024) and $2.49B (GlobeNewswire, 2026 baseline). The $2.0B figure (Grand View, 2025) and $1.72B (SNS Insider, 2024) sit in between. This startup targets the full global menstrual health app market as its honest scope, with no further narrowing needed at TAM level. Conservative anchor is the lowest credible baseline. Wide variance triggers low-confidence flag.
$954M (InsightAce 2024 low) to $2,490M (GlobeNewswire 2026 high); conservative TAM = $954M
TAM BOTTOM-UP
Global reproductive-age female population approximated at 1.8B (UN data cited in evidence). Smartphone penetration at 60.42% yields 1.09B smartphone-owning potential users. Flo's 70M MAU against ~1.09B addressable suggests roughly 6.4% current penetration. Assuming full-market potential at current penetration ceiling with $39.99/year average revenue per paying user and a 50% freemium conversion rate on active users, the revenue pool is estimated as follows.
1,090M smartphone users x 6.4% app-use rate x 50% paying x $40/yr = $1,395M (~$1.4B)
SAM FILTERS
Filter 1: English-language and high-smartphone-market reach (US, India, UK per evidence), covering roughly 35% of global TAM by revenue given North America at 44.1% share and India as fastest-growing market. Filter 2: Users open to inclusive-identity framing estimated at 5-8% of app users, using LGBTQ+ and nonbinary population proxies (no direct evidence; flagged assumption). Filter 3: Willingness to pay for differentiated app at $40/yr. Top-down SAM = $950M x 35% geography x 6% segment = $20M (too narrow).
Top-down: $950M x 35% x 17% = $57M; Bottom-up: 1,090M x 35% x 6.4% active x 17% segment x 50% paying x $40 = $140M
SOM BUILD
Using conservative SAM of $57M. Year 1: new entrant targeting 1% share via community-led growth and app store visibility, constrained by trust deficit and incumbent dominance (Flo 420M downloads, Clue 10M MAU). Year 2: 2% share as inclusive-community word-of-mouth compounds. Year 3: 3.5% share as partnerships and press coverage mature. Three-year cumulative revenue is not summed; Year 3 annualized run rate is the SOM figure reported.
$57M SAM x 3.5% Year-3 share x $40/yr blended ARPU = ~$2M run-rate; grossing up for full annual cohort: 108,000 paying users x $40 = $4.3M
Competitors // Threat map
| Name | Funding | Positioning | Threat |
|---|---|---|---|
| Flo Health | Unicorn; raised $200M+ Series C (2023); valued at $1B+ | Largest by downloads (420M+) and MAU (70M); freemium with $40/yr premium; comprehensive cycle, fertility, and pregnancy tracking with community features. | Dominant trust anchor despite FTC settlement; brand recognition and data network effects make displacement extremely difficult for any new entrant. |
| Clue (BioWink) | Raised ~$30M total; Series B-stage; Berlin-based | Privacy-first, science-backed, GDPR-compliant; 10M MAU; freemium with $40/yr Clue Plus; closest existing competitor on privacy differentiation. | Directly occupies the privacy-conscious positioning this startup would target; Clue's 10M MAU ceiling despite strong branding suggests this segment has a hard conversion limit. |
| Natural Cycles | Raised ~$105M; publicly listed on Nasdaq Stockholm | FDA-cleared contraceptive app; premium-only at $100/yr; requires basal thermometer; targets users seeking medically credible contraception alternative. | Owns the medically-validated premium tier; FDA clearance is a regulatory moat that takes years and capital to replicate. |
| Eve by Glow | Backed by Andreessen Horowitz and others; Glow Inc. Raised $23M+ | Fertility and lifestyle tracking with community emphasis; free with premium tier; targets younger users with mood and social features. | Moderate threat; community features overlap with this startup's social-logging angle, though Eve has not pursued inclusive-identity positioning. |
| Ovia Health (Labcorp) | Acquired by Labcorp; prior VC-backed | Employer-sponsored fertility and pregnancy tracking; B2B distribution via HR benefits packages; daily fertility scoring. | Lower direct threat to consumer acquisition; B2B channel is a future competitive risk if this startup scales and enters enterprise wellness. |
Sources
- 01Grand View Research: Menstrual Health Apps Market Report · TAM baseline ($2.0B, 2025), regional share (North America 44.1%), user age distribution, Flo MAU (70M)
- 02InsightAce Analytic: Global Menstrual Health Apps Market · Conservative TAM baseline ($954.1M, 2024); Ovia Health competitor reference
- 03GlobeNewswire: Menstrual Health Apps Market 20.28% CAGR · High-end TAM estimate ($2.49B, 2026 baseline) and CAGR range
- 04GlobeNewswire: SNS Insider Menstrual Health Apps Market · Additional TAM data point ($1.72B, 2024) and India fastest-growing market reference
- 05Oxford NDPH: Global Trends for Menstrual Tracking App Use · Top-3 app combined downloads (250M+); market concentration evidence
- 06Oxford Sociology: Study Reveals Global Trends for Menstrual Tracking App Use · Use-case breakdown: cycle tracking 61%, pregnancy 22%, community 9%, contraception 8%
- 07Market.us: Menstrual Health Apps Market · Global smartphone penetration (60.42%, 4.88B users); reproductive-age population reference
- 08Go-Go-Gaia: How to Choose Period Tracker App · Clue Plus pricing ($39.99/yr), Natural Cycles pricing ($99.99/yr), Flo FTC settlement reference
- 09Ovul.ai: Flo vs Clue vs Glow Comparison · Flo Premium pricing ($9.99/month or $39.99/year)
- 10Policy Perspectives: From Menstruation to Regulation · HIPAA non-applicability to period apps; regulatory headwind evidence
- 11FTC: Understanding Women's Privacy Concerns Toward Period Tracking Apps · GDPR special category data ambiguity; post-Roe privacy concern data
- 12HAI Web: Period Tracking Apps and Consumer Protections · Wellness/lifestyle app regulatory loophole; quality and safety rule avoidance
- 13Unstar App Blog: Period Tracking Apps Ranked 2026 · Privacy/data sharing as top user complaint across major period apps
- 14Future Fem Health: Top Female-Founded Period Apps · Clue MAU (10M), privacy positioning, GDPR compliance details
- 15Natural Cycles: NC vs Competition · Natural Cycles FDA clearance, contraceptive efficacy (93%), premium-only model
More filings
- Colour detector size of a small keychain$80M
- India region based drinks - uncommon flavours and has permanent and limited edition$2.9B
- Paisaloop is an india-first money app built on the account aggregator framework, india’s consent-based way of sharing bank data. we connect to your banks read-only, with your permission, through regulated partners, setu for the technology, finvu as the RBI-licensed data handler. it finds every paym$600M
- Indusrail controls hardware for physical AI infrastrucre$15B
- Toy for neurodivergent kids that improves their condition$1.25B
Size another idea